Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.
Department of Epidemiology, University of Washington Seattle, WA, USA.
Lee Ann
LA
Campbell
Department of Environmental and Occupational Health Sciences, Department of Pathology, University of Washington Seattle, WA, USA.
Michael E
ME
Rosenfeld
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000209:etiology* / Q000517:prevention & control; D023521:Chlamydophila Infections / Q000150:complications* / Q000473:pathology*; D016993:Chlamydophila pneumoniae / Q000302:isolation & purification* / Q000502:physiology; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D017211:Treatment Failure
D000900:Anti-Bacterial Agents
Chlamydia pneumoniae; antibiotics; atherosclerosis; clinical trials; persistence